Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2024

SIGNIFICANT ACCOUNTING POLICIES

Schedule of net sales

		Three Months Ended March 31,
		2024				2023
Sales/access fees		$	2,205			$	1,010
Project support income			-				25,817
Distribution rights income			-				8,626
Membership/program fees			1,415				4,989
Net sales		$	3,620			$	40,442

Schedule of changes in deferred revenue

Balance as of December 31, 2023
Short term		$	-
Long term			4,045
Total as of December 31, 2023			4,045
Balance as of March 31, 2024			4,045
Less short term			-
Long term		$	4,045

Schedule of assets and liabilities measured at fair value on a recurring basis

		March 31, 2024
		Level 1				Level 2				Level 3				Total
Liabilities:
Derivative liability		$	-			$	-			$	80,190			$	80,190
		$	-			$	-			$	80,190			$	80,190

		December 31, 2023
		Level 1				Level 2				Level 3				Total
Liabilities:
Derivative liability		$	-			$	-			$	53,460			$	53,460
		$	-			$	-			$	53,460			$	53,460

Schedule of derivative liability

		Derivative Liability

Fair value as of December 31, 2023		$	53,460
Fair value at issuance			26,730
Fair value as of March 31, 2024		$	80,190

Schedule of weighted average diluted shares

		Three Months Ended
		March 31,
		2024				2023
Shares underlying options outstanding			935,068				882,530
Shares underlying warrants outstanding			1,765,856				676,447
Convertible preferred stock outstanding			240,000				240,000
			2,940,924				1,798,977